ResistanceBio
YC W19San Francisco, US · Founded 2016 · 15 employees · Inactive · 3 known investors
ResistanceBio develops treatments to address drug resistance in cancer patients.
Founders & leadership· Y Combinator alumni (W19)
Nicholas GoldnerinCEO/Founder
Christopher BulowinFounder
Investors · 3
In the news
- What is Brief History of resistanceBio Company? – businessmodelcanvastemplate.comcanvasbusinessmodel.com · 2024
- ResistanceBio - 2025 Company Profile, Team, Funding & Competitors - Tracxntracxn.com · 2021
- ResistanceBio - 2025 Funding Rounds & List of Investors - Tracxntracxn.com · 2021